ZVSA - Balance Sheet - ZyVersa Therapeutics, Inc.

Current Liabilities	11.2 M
Accounts Payable	9.34 M
Short-Term Debt	0
Other Current Liabilities	1.89 M
Non-Current Liabilities	852 K
Long-Term Debt	0
Other Non-Current Liabilities	852 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	1.5	3.1	5.9	0.3	0.2
Short Term Investments	0	0	0	0	0
Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Other Current Assets	0.2	0.2	0.5	0.5	0.2
Total Current Assets	1.7	3.4	6.4	0.8	0.3
PP&E	0	14.8 K	0.1	27.7 K	38.1 K
Intangible Assets	18.6	18.6	100.1	0	0
Goodwill	0	0	11.9	0	0
Long Term Investments	0	0	0	0	0
Other Long Term Assets	0.2	98.5 K	46.7 K	0.3	0.3
Other Assets	0	0	0	0	0
Total Assets	20.6	22.1	118.5	1.1	0.7
LIABILITIES
Accounts Payable	9.3	8.4	6.0	2.0	2.3
Short Term Debt	0	8.66 K	0.1	9.2	2.1
Other Current Liabilities	1.9	1.8	1.9	2.5	3.1
Total Current Liabilities	11.2	10.2	8.2	13.6	7.6
Long Term Debt	0	0	0	0	1.7
Deferred Tax Income	0.9	0.8	10.3	0	0
Other Liabilities	0	0	0	0	0
Total Liabilities	12.1	11.0	18.5	13.6	9.2
EQUITY
Common Stock	251	405	902	242	242
Retained Earnings	(112 632.6)	(103.2)	(4.9)	(52.9)	(44.8)
Other Accumulative Comprehensive Income/Loss	0	0	0	(0.3)	(0.3)
Total Equity	8 516.4	11.1	100.0	(12.5)	(8.6)
Total Liabilities and Equity	20.6	22.1	118.5	1.1	0.7
SHARES OUTSTANDING
Common Shares Outstanding	11.1	97.5 K	25.9 K	46.6 K	46.6 K

Free